Yahoo Web Search

Search results

    • Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

      The Joplin Globe· 6 days ago

      TORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for

    • Q1 2024 Monday.Com Ltd Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 9 hours ago

      G&A expense was $17.6 million in Q1 '24 or 8% of revenue compared to 10% in Q1 '23. Net income was $31.7 million in ...diluted shares outstanding. Total employee head count ...